Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin

被引:47
作者
Natsume, T [1 ]
Watanabe, J [1 ]
Tamaoki, S [1 ]
Fujio, N [1 ]
Miyasaka, K [1 ]
Kobayashi, M [1 ]
机构
[1] Teikoku Hormone Mfg Co Ltd, Takatsu Ku, Kanagawa 2138522, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 2000年 / 91卷 / 07期
关键词
TZT-1027; microtubule polymerization; tubulin binding; antimicrotubule agent; dolastatin; 10;
D O I
10.1111/j.1349-7006.2000.tb01007.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TZT-1027, a derivative of dolastatin 10 isolated from the Indian Ocean sea hare Dolabella auricularia in 1987 by Pettit Et nl., is a potent antimicrotubule agent, We have compared the activity of TZT-1027 with that of dolastatin 10 as well as the vinca alkaloids vinblastine (VLB), vincristine (VCR) and vindesine (VDS), TZT-1027 and dolastatin 10 inhibited microtubule polymerization concentration-dependently at 1-100 mu M with IC50 values of 2.2+/-0.6 and 2.3+/-0.7 mu M, respectively. VLB, VCR and VDS inhibited microtubule polymerization at 1-3 mu M with IC50 values of 2.7+/-0.6, 1.6+/-0.4 and 1.6+/-0.2 mu M, respectively, but showed a slight decrease in inhibitory effect at concentrations of 10 mu M or more, TZT-1027 also inhibited monosodium glutamate-induced tubulin polymerization concentration-dependently at 0.3-10 mu M, with an IC50 of 1.2 mu M, whereas VLB was only effective at 0.3-3 mu M, with an IC50 of 0.6 mu M, and caused so-called "aggregation" of tubulin at 10 mu M. Scatchard analysis of the binding data for [H-3]VLB suggested one binding site (K-d 0.2 +/- 0.04 mu M and B-max 6.0+/-0.26 nM/mg protein), while that for [H-3]TZT-1027 suggested two binding sites, one of high affinity (K-d 0.2+/-0.01 mu M and B-max 1.7+/-0.012 nM/mg protein) and the other of low affinity (K-d 10.3+/-1.46 mu M and B-max 11.6+/-0.83 nM/mg protein), [3H]TZT-1027 was completely displaced by dolastatin 10 but only incompletely by VLB, [H-3]VLB was completely displaced by dolastatin 10 and TZT-1027, Furthermore, TZT-1027 prevented [H-3]VLB from binding to tubulin in a non-competitive manner according to Lineweaver-Burk analysis. TZT-1027 concentration-dependently inhibited both [H-3]guanosine 5'-triphosphate (GTP) binding to and GTP hydrolysis on tubulin, VLB inhibited the hydrolysis of GTP on tubulin concentration-dependently to a lesser extent than TZT-1027, but no inhibitory effect of VLB on [H-3]GTP binding to tubulin was evident even at 100 mu M. Thus, TZT-1027 affected the binding of VLB to tubulin, but its binding site was not completely identical to that of VLB, TZT-1027 had a potent inhibitory effect on tubulin polymerization and differed from vinca alkaloids in its mode of action against tubulin polymerization.
引用
收藏
页码:737 / 747
页数:11
相关论文
共 44 条
[11]  
HAAR E, 1996, BIOCHEMISTRY-US, V35, P243
[12]   EFFICIENT STEREOSELECTIVE SYNTHESIS OF DOLASTATIN-10, AN ANTINEOPLASTIC PEPTIDE FROM A SEA HARE [J].
HAMADA, Y ;
HAYASHI, K ;
SHIOIRI, T .
TETRAHEDRON LETTERS, 1991, 32 (07) :931-934
[13]   GLUTAMATE-INDUCED POLYMERIZATION OF TUBULIN - CHARACTERISTICS OF THE REACTION AND APPLICATION TO THE LARGE-SCALE PURIFICATION OF TUBULIN [J].
HAMEL, E ;
LIN, CM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1981, 209 (01) :29-40
[14]   Microtubule-based motor proteins: New targets for enhancing drug delivery? [J].
HammAlvarez, SF .
PHARMACEUTICAL RESEARCH, 1996, 13 (04) :489-496
[15]  
HIMES RH, 1976, CANCER RES, V36, P3798
[16]   MAYTANSINE INHIBITS NUCLEOTIDE BINDING AT THE EXCHANGEABLE SITE OF TUBULIN [J].
HUANG, AB ;
LIN, CM ;
HAMEL, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (03) :1239-1246
[17]   (+)-discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest [J].
Hung, DT ;
Chen, J ;
Schreiber, SL .
CHEMISTRY & BIOLOGY, 1996, 3 (04) :287-293
[18]  
HYAMS JS, 1994, MICROTUBULES, P1
[19]   VINORELBINE TARTRATE AND PACLITAXEL COMBINATIONS - ENHANCED ACTIVITY AGAINST IN-VIVO P388 MURINE LEUKEMIA-CELLS [J].
KNICK, VC ;
EBERWEIN, DJ ;
MILLER, CG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (14) :1072-1077
[20]   Antitumor activity of TZT-1027, a novel dolastatin 10 derivative [J].
Kobayashi, M ;
Natsume, T ;
Tamaoki, S ;
Watanabe, J ;
Asano, H ;
Mikami, T ;
Miyasaka, K ;
Miyazaki, K ;
Gondo, M ;
Sakakibara, K ;
Tsukagoshi, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (03) :316-327